CORRECTION: The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting o
Last week's meeting marked a prelude to GVN's international meeting in Durban, South Africa, September 16-18, 2024
TAMPA, Fla., Aug. 31, 2024 (GLOBE NEWSWIRE) - A correction has been issued for the release disseminated on August 29th. Sten Vermund's full title was corrected to Sten Vermund, MD, PhD, GVN President and Professor of Yale University, USA. The complete and corrected release follows.
To mitigate the mpox outbreak, the Global Virus Network (GVN) is leading a panel of experts to develop guidelines and streamline testing standards, including strengthening infrastructure to sequencing and early detection. On August 22, 2024, the GVN, headquartered at the University of South Florida, USA, convened a critical mpox discussion online with leaders from the World Health Organization (WHO), Africa Centers for Disease Control and Prevention (Africa CDC), the Foundation for Innovative New Diagnostics (FIND), the Coalition for Epidemic Preparedness Innovations (CEPI), major industry partners, renowned virologists, and public health experts at the forefront of the mpox outbreak response.
Lorenzo Subissi, PhD, WHO's Mpox Task Force lead, advised the group that the current mpox epidemic was escalated to a grade 3 emergency, requiring a major to maximal WHO response. He reported that 38% of children infected are under age 10 and noted sustained human-to-human transmission of clade 1b in Africa.
Mpox is a viral infection that spreads through close contact, including sexual relations, and causes flu-like symptoms, including fever, chills, muscle aches, and pus-filled lesions. Mpox is usually mild but sometimes fatal, mostly in children. The new clade 1b variant is responsible for the rising infections, primarily in the Democratic Republic of the Congo and identified in Burundi, Kenya, Rwanda, Uganda, and Thailand, as well as reported in the Central African Republic, the Republic of Congo, and Sweden.
The discussion highlighted the urgent need to enhance diagnostic capabilities, vaccine development, and global collaboration to mitigate the impact of the mpox outbreak, particularly in regions most at risk.
To facilitate recommendations catalyzed by the discussion, the GVN assembled a subcommittee on point-of-care diagnostics chaired by Rachel Roper, PhD, Professor of Microbiology and Immunology at East Carolina University, USA and Co-chair of GVN's Mpox Action Committee, Marion Koopmans, DVM, PhD, Erasmus Medical Center, Netherlands, a GVN Center of Excellence, and Deborah Williamson, PhD, Professor of Public Health Microbiology, University of Glasgow, United Kingdom, a GVN Center of Excellence, and Director of the UK Health Security Agency. The subcommittee is meeting weekly to develop global testing and diagnostic standards and generate suggestions through a collaborative whitepaper addressing issues such as sample collection, assays, and clinical triage procedures for frontline workers.
“It's not just how a sample is transported,” Dr. Roper said, “but what type of sample is collected. For mpox, each lesion can have unique viral populations, and we need to have a universal sample type defined and well documented to aid surveillance.”
During the meeting, Emmanuel Agogo, PhD, Director of Pandemic Threats at FIND, Switzerland, emphasized the need for local capacity building: “To effectively combat mpox, we must empower local health systems and researchers. This will not only help contain the current outbreaks but also build long-term resilience against future threats. In particular, the need for decentralized diagnostic options is critical for surveillance, access to therapeutics and effective vaccine roll out.”
Maggie L. Bartlett, PhD, Program Director at the GVN and faculty member at Johns Hopkins Bloomberg School of Public Health, USA, a GVN Center of Excellence, emphasized the importance of inclusive and equitable strategies: “Our efforts must reach those in the most affected regions, and we must prioritize health equity in our response to ensure that no one is left behind.”
Laurens Liesenborghs, MD, PhD, Assistant professor of Emerging Infectious Diseases at the Institute of Tropical Medicine (ITM), Belgium, member of ITM's multidisciplinary Outbreak Research Team, and member of the GVN Mpox Action Committee, echoed the call for an innovative approach: “We cannot be content with the status quo. Our goal is to develop tools and strategies that are not only effective but also scalable and sustainable. This is a global challenge that demands a global response.”
Michael Mina, MD, PhD, Chief Scientific Officer of eMed, USA, said “Rapid tests and PCR tests are not mutually exclusive. In fact, we learned during COVID how useful a dual strategy can be and how these can be incredibly powerful additive tools in our public health toolbox. We need the big companies to step it up and develop rapid diagnostics and research funding incentives from governments to ensure we don't face the same fallout with the crash of small companies after the surge.”
Yenew Kebede Tebeje, MD, Head of Division of Laboratory Systems at Africa CDC advised, “Mpox poses a significant threat to public health, particularly in regions where health systems are already stretched thin. To effectively combat this virus, we must strengthen our surveillance, diagnostic, and response capabilities across Africa. Our collective efforts must ensure that we are not only containing the current outbreaks but also building the resilience needed to face future health challenges.”
In addition to addressing the immediate response, the meeting also focused on long-term strategies for pandemic preparedness and response. The participants discussed the critical role of partnerships between global organizations like WHO, GVN, Africa CDC, CEPI and FIND in driving innovation and ensuring that resources are directed where they are most needed.
Sten Vermund, MD, PhD, GVN President and Professor of Yale University, USA, said, "The initiatives originating from the meeting represent part of the GVN effort to assist in the global effort to combat mpox and other emerging viral threats. Collaboration is imperative and we are keen that the GVN help leverage and focus resources and expertise helping to mitigate the mpox outbreak and plan for future threats.”
GVN's coalition of the world's leading virology researchers, who work together to prevent illness and death from viral disease, will continue these discussions about the mpox outbreak amid high-level scientific sessions examining pandemic preparedness and current threats, including at GVN's International Annual Scientific Meeting, “Navigating Virology's Frontiers in Africa,” co-hosted by the Centre for the AIDS Programme of Research in South Africa (CAPRISA), a GVN Center of Excellence, September 16-18, 2024.
Salim Abdool Karim, MB, ChB, director of CAPRISA and CAPRISA Professor of Global Health at Columbia University, USA, is chair of the Africa CDC Emergency Consultative Group and warned that mpox spread is eminent, but with a global response it can be controlled and stopped. Dr. Karim also said the outbreak is particularly concerning as it disproportionately affects young people. He continued, “I look forward to continuing these discussions at the GVN international meeting in Durban as we tackle this rising threat, among other pressing global issues, including COVID-19, scientific misinformation, and pandemic preparedness.”
During GVN's international meeting, experts will exchange ideas on themes including: evading viral evasion; translational virology and complex co-infections; training the next generation; post-viral diseases; bats, rats, and other vectors; genetic sequences and epidemiological insights; cutting-edge diagnostics and therapeutics; regional responses to disease; perspectives from agencies; pandemic preparedness; and combating scientific misinformation.
About the Global Virus Network (GVN)
The GVN is essential and critical in the preparedness, defense, and first research response to emerging, existing, and unidentified viruses that pose a clear and present threat to public health. Working in close coordination with established national and international institutions, the GVN is a coalition comprised of eminent human and animal virologists from 80+ Centers of Excellence and Affiliates in 40+ countries, working collaboratively to train the next generation, advance knowledge about how to identify and diagnose pandemic viruses, mitigate and control how such viruses spread and make us sick, as well as develop drugs, vaccines, and treatments to combat them. No single institution in the world has expertise in all viral areas other than the GVN, which brings together the finest medical virologists to leverage their individual expertise and coalesce global teams of specialists on the scientific challenges, issues, and problems posed by pandemic viruses. The GVN is a non-profit 501(c)(3) organization. For more information, please visit www.gvn.org.
For more information, please contact:
Linman Li at linmanli@gvn.org
- 长深睿智闪耀第六届河南省教育装备博览会,助推国产化教育创新及发展
- Bridgestone推出的印地自动驾驶挑战赛将于2024年7月重返古德伍德速度节
- 桥彼道完成 B2 轮融资,为市场扩张及产品创新注入动力
- 徐冬冬《三大队》入围百花奖最佳女配角提名,“加钱姐”再获高赞
- Mary Kay 公司宣布进军丹麦,加强其对斯堪的纳维亚女性赋权的承诺
- 科技赋能金融支农——常德农发行实现全省系统内首笔“智粮贷”抵押贷款投放
- 高等教育出版社出版发行《综合集成医学经络调理师培训教程》
- Mavenir为Partner Israel移动网络带来增强型4G室内覆盖
- 华琪舍利子博物馆与马来西亚大马佛教文化总会供展
- AMGTA在年度成员峰会上表彰可持续发展成就
- Medidata推出Clinical Data Studio,利用人工智能革新临床试验数据体验
- 鸿运开年必胜,必胜客×永劫无间带来国潮新体验
- 湖北中工集团九钢绿设建筑工程有限公司高品质生活的象征
- 全面领跑行业增长,安能物流净利劲增173.9% ,开启高质量增长快车道
- 人民院线重磅首推!电影《你是我的英雄》定档5月20日热血上映
- 1个月盈利!万百万博士开创2024年创业新爆品:盗龄医生AI石熏天灸馆
- 许昌长葛播音主持导演影视表演艺考培训哪家好-卓群艺培
- Sintavia宣布斥资2500万美元扩建佛罗里达州好莱坞工厂
- Ambassador Noble C.K. McWhorter Grants Hermes An Esteemed McWhorter Family Trust Warrant For Recogni
- 海南华素制药检测中心:科技引领,质量保障
- 中信银行大同分行:现金服务暖人心 精准发力赢客户
- POSCO and Hazer Collaborate on Clean Hydrogen Production Technology for Low Carbon Steel
- 中国宣传网——构筑行业宣传高地,诚邀企业品牌共襄盛举,共享万亿级广告市场盛宴
- 汉江国投携手浪潮海岳,激活投资管理数字化新效能
- 打卡香港库洛米展!暑假必到YOHO MALL形点商场
- 扁平吊装带(单层双眼)帆布扁平吊装带配套用扁平环眼吊装带
- SIGGRAPH 2024丨Style3D 6篇论文揭秘时尚未来
- 泼墨挥毫·悬壶济世——书法名家刘兴红百家媒体聚焦报道
- 道泓健康——承中医之智慧,启健康之新篇
- 让闺蜜先老 我要滤镜之谜的FILTERS滤镜之谜面膜究竟有何魅力
推荐
- 男子“机闹”后航班取消,同机旅客准备集体起诉 1月4日,一男子大闹飞机致航班取消的新闻登上 资讯
- 王自如被强制执行3383万 据中国执行信息公开网消息,近期,王自如新增一 资讯
- 国足13次出战亚洲杯首次小组赛0进球 北京时间1月23日消息,2023亚洲杯小组 资讯
- 中央气象台连发四则气象灾害预警 暴雪橙色预警+冰冻橙色预警+大雾黄色预警+ 资讯
- 奥运冠军刘翔更新社交账号晒出近照 时隔473天更新动态! 2月20日凌晨2点,奥运冠军刘翔更新社交账号晒 资讯
- 一个“江浙沪人家的孩子已经不卷学习了”的新闻引发议论纷纷 星标★ 来源:桌子的生活观(ID:zzdshg) 没 资讯
- 看新东方创始人俞敏洪如何回应董宇辉新号分流的? (来源:中国证券报) 东方甄选净利润大幅下滑 资讯
- 大家一起关注新疆乌什7.1级地震救援见闻 看到热气腾腾的抓饭马上就要出锅、村里大家 资讯
- 海南大学生返校机票贵 有什么好的解决办法吗? 近日,有网友在“人民网领导留言板&rdqu 资讯
- 周星驰新片《少林女足》在台湾省举办海选,吸引了不少素人和足球爱好者前来参加 周星驰新片《少林女足》在台湾省举办海选,吸 资讯